-
Product Insights
NewNT 3 Growth Factor Receptor – Drugs In Development, 2024
The NT 3 Growth Factor Receptor pipeline drugs market research report outlays comprehensive information on the NT 3 Growth Factor Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, Genetic Disorders, and Hematological Disorders which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Alzheimer's Disease, Parkinson's Disease, Letterer-Siwe Disease (Multifocal and multisystemic...
-
Product Insights
NewHigh Affinity Nerve Growth Factor Receptor – Drugs In Development, 2024
The High Affinity Nerve Growth Factor Receptor pipeline drugs market research report outlays comprehensive information on the High Affinity Nerve Growth Factor Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, Ophthalmology, and Hematological Disorders which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Alzheimer's Disease, Pain, Keratoconjunctivitis Sicca (Dry Eye), Keratitis,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABBVCLS-7262 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABBVCLS-7262 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ABBVCLS-7262 in Amyotrophic Lateral Sclerosis Drug Details: ABBVCLS-7262 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sonpiretigene Isteparvovec in Retinitis Pigmentosa (Retinitis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sonpiretigene Isteparvovec in Retinitis Pigmentosa (Retinitis) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sonpiretigene Isteparvovec in Retinitis Pigmentosa (Retinitis) Drug Details: Sonpiretigene...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sonpiretigene Isteparvovec in Juvenile Macular Degeneration (Stargardt Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sonpiretigene Isteparvovec in Juvenile Macular Degeneration (Stargardt Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sonpiretigene Isteparvovec in Juvenile Macular Degeneration (Stargardt...
-
Company Insights
NewHartford Financial Services Group Inc. – Digital Transformation Strategies
This report provides insight into Hartford's tech activities, including its digital transformation strategies, its innovation programs, its technology initiatives, its estimated ICT budget, and its major ICT contracts. The Hartford Financial Services Group Inc (Hartford) is a financial holding group. The group, through its subsidiaries, provides a range of property and casualty insurance, group benefits and mutual funds to individuals and business customers. It offers insurance products for homeowners, renters, workers’ compensation, business income, commercial property, data breach, auto, general...
-
Product Insights
Likelihood of Approval Analysis for Neutropenia
Overview How likely is it that the drugs in Neutropenia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neutropenia Overview Neutropenia is an abnormally low concentration of neutrophils (a type of...
-
Product Insights
Likelihood of Approval Analysis for Allergic Conjunctivitis
Overview How likely is it that the drugs in Allergic Conjunctivitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Allergic Conjunctivitis Overview Allergic conjunctivitis occurs when the clear layer of tissue...
-
Thematic Analysis
NewBanking and Payments M&A Deals, Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Banking & Payments Sector
-
Product Insights
Likelihood of Approval Analysis for Cytopenia
Overview How likely is it that the drugs in Cytopenia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cytopenia Overview Cytopenia is characterized by a reduction in blood cell numbers, encompassing...